Importantly, over 90% of diabetic individuals suffer from type 2 diabetes (T2D) 4
Water GLP-1 medications may increase the risk of dehydration if you dont feel as hungry or thirsty
Differences in Mechanisms While both medications are approved obesity treatments that mimic the GLP-1 hormone, the gut hormone that regulates blood sugar levels and appetite, leading to reduced caloric intake, Zepbound is a dual agonist
The FDA similarly removed it from its shortage list on February 21, 2025, but this time, it designated off-ramps for production of compounded types right off the bat: Technically, 503A pharmacies have until April 22 to quit making semaglutide drugs, while 503B facilities have until May 22
Gastrointestinal Effects: Mild nausea, abdominal cramping, bloating, and flatulence may occur, especially during the initial supplementation period